Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Lymphat Res Biol. 2021 Feb;19(1):20-22. doi: 10.1089/lrb.2020.0115. Epub 2021 Jan 22.
Debulking via power-assisted liposuction has been established internationally as the gold standard for patients with chronic fat-dominant lymphedema. In this study we share our experience implementing a debulking surgery program in the United States. A retrospective review was performed of patients who underwent debulking surgery using power-assisted liposuction at a single institution. Between December 2017 and January 2020, 39 patients with lymphedema underwent 41 extremity debulking procedures. In patients with lymphedema of the upper extremity, median excess volume reduction was 111% at 6 months and 116% at 12 months post-operatively. In patients with lymphedema of the lower extremity, excess volume reduction was 82% at 6 months and 115% at 12 months post-operatively. L-Dex and quality of life improved across all domains in upper and lower extremity patients as well. Debulking with power-assisted liposuction is an effective treatment for chronic lymphedema, supported by improvement in both objective and subjective metrics.
动力辅助吸脂术的去脂术已在国际上被确立为慢性脂肪为主型淋巴水肿患者的金标准。在这项研究中,我们分享了我们在美国实施去脂手术项目的经验。对一家机构接受动力辅助吸脂术去脂手术的患者进行了回顾性研究。在 2017 年 12 月至 2020 年 1 月期间,39 例淋巴水肿患者接受了 41 次四肢去脂手术。在上肢淋巴水肿患者中,术后 6 个月和 12 个月时,多余体积减少中位数分别为 111%和 116%。在下肢淋巴水肿患者中,术后 6 个月和 12 个月时,多余体积减少中位数分别为 82%和 115%。上肢和下肢患者的 L-Dex 和生活质量在所有领域均有所改善。动力辅助吸脂术去脂术是一种有效的慢性淋巴水肿治疗方法,客观和主观指标均有改善。